Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial

Peer Review reports

Original Submission
2 Jul 2013	Submitted	Original manuscript
16 Jul 2013	Reviewed	Reviewer Report - Yeong Yeh Lee
6 Aug 2013	Reviewed	Reviewer Report - Edoardo Savarino
16 Sep 2013	Author responded	Author comments - Hubert Moennikes
Resubmission - Version 2
16 Sep 2013	Submitted	Manuscript version 2
Publishing
24 Sep 2013	Editorially accepted
1 Oct 2013	Article published	10.1186/1471-230X-13-145

Back to article page